Recombinant Human Interferon-γ Modulates Rift Valley Fever Virus Infection in the Rhesus Monkey (Q40744262)

reason for preferred rank

23 September 2017

Recombinant Human Interferon-γ Modulates Rift Valley Fever Virus Infection in the Rhesus Monkey (English)

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

20 November 2022

Recombinant human interferon-gamma modulates Rift Valley fever virus infection in the rhesus monkey (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1774469

Rift Valley fever phlebovirus

20 November 2022

main subject

0 references

1 reference

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

20 November 2022

Rift Valley fever virus

object named as

Rift Valley Fever Virus

1 reference

3

Peters CJ

1 reference

23 September 2017

J. C. Morrill

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1774469

20 November 2022

C. W. Czarniecki

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1774469

20 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1774469

20 November 2022

publication date

1 October 1991

1 reference

full work available at URL

23 September 2017

http://www.liebertpub.com/doi/pdf/10.1089/jir.1991.11.297

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Journal of Interferon Research

20 November 2022

published in

1 reference

23 September 2017

11

1 reference

23 September 2017

297-304

1 reference

23 September 2017

5

1 reference

Rift Valley Fever virus infections in Egypt: pathological and virological findings in man

23 September 2017

2

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

The Rift Valley fever epizootic in Egypt 1977–1978 1. Description of the epizootic and virological studies

20 November 2022

3

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness

20 November 2022

4

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

General aspects of the 1987 Rift Valley fever epidemic in Mauritania

20 November 2022

6

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Rift Valley fever ocular manifestations: observations during the 1977 epidemic in Egypt

20 November 2022

8

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Evaluation of a new Rift Valley fever vaccine: safety and immunogenicity trials

20 November 2022

10

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Prophylaxis of Rift Valley fever with antiviral drugs, immune serum, an interferon inducer, and a macrophage activator

20 November 2022

11

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Prevention of Rift Valley fever in rhesus monkeys with interferon-alpha.

20 November 2022

12

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Experimental Rift Valley fever in rhesus macaques

20 November 2022

13

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Pathogenesis of Rift Valley fever in rhesus monkeys: role of interferon response

20 November 2022

14

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Human leukocyte interferon produced by E. coli is biologically active

20 November 2022

15

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Pathogenesis of Rift Valley fever virus (RVFV) in inbred rats

20 November 2022

16

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Recombinant HuIFN-gamma prevents herpes simplex keratitis in African green monkeys: demonstration of synergism with recombinant HuIFN-alpha 2.

20 November 2022

17

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Circulating interferon in rabbits and monkeys after administration of human gamma interferon by different routes

20 November 2022

20

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Pharmacokinetic studies with human and rat interferons-gamma in different species.

20 November 2022

21

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Synergistic activities of type I (α, β) and type II (γ) murine interferons

20 November 2022

23

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons

20 November 2022

24

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Requirement for IFN gamma in potentiation of interferon's antiviral and anticellular activities: identity of mouse and human systems

20 November 2022

25

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Potentiation of the antiviral and anticellular activities of interferons by mixtures of HuIFN-gamma and HuIFN-alpha or HuIFN-beta

20 November 2022

27

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

Circulating interferon in rabbits after simultaneous intramuscular administration of human alpha and gamma interferons

20 November 2022

28

1 reference

https://api.crossref.org/works/10.1089/JIR.1991.11.297

20 November 2022

Identifiers

1 reference

23 September 2017

1 reference